The FUTURE‐I study aimed to assess preliminary safety and effectiveness with the long‐term clinical and imaging follow‐up for the Firesorb (MicroPort, Shanghai, China), a thinner‐strut sirolimus‐eluting bioresorbable scaffold (BRS). Click to show full abstract
The FUTURE‐I study aimed to assess preliminary safety and effectiveness with the long‐term clinical and imaging follow‐up for the Firesorb (MicroPort, Shanghai, China), a thinner‐strut sirolimus‐eluting bioresorbable scaffold (BRS).
               
Click one of the above tabs to view related content.